Argatroban dosage and administration: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Argatroban#Adult Indications and Dosage]]
{{Argatroban}}
{{CMG}}; {{AE}} {{JH}}
 
==Dosage and Administration==
 
Each 50 mL glass vial contains 50 mg argatroban (1 mg/mL); and, as supplied, is ready for intravenous infusion. Dilution is not required.
 
Argatroban Injection is a clear, colorless to pale yellow solution. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit. Do not use if solution is cloudy, contains precipitates, or if the white flip top cap is not intact.
 
Vial may be inverted for use with a medical infusion set.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = ARGATROBAN INJECTION, SOLUTION [GLAXOSMITHKLINE LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c9616c0-a299-4fd5-c8ae-79e6db453595 | publisher =  | date =  | accessdate = }}</ref>
 
==Reference==
 
{{reflist}}
 
{{FDA}}
 
[[Category:Cardiovascular Drugs]]
[[Category:Hematology]]
[[Category:Drugs]]

Latest revision as of 18:38, 21 July 2014